FDA Issues Warning about New Class of Type 2 Diabetes Drugs
![diabetes](https://injurylawyer-news.com/wp-content/uploads/Actos-diabetes-e1382646777950.jpg)
The FDA has issued a new diabetes drug warning concerning a class of drugs called SGLT2 inhibitors that are designed to treat type 2 diabetes. The warning states that the agency has received reports of ketoacidosis, a condition involving dangerously high levels of acid in... Read More